Related Experiment Video
Updated: Aug 18, 2026

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
Published on: July 1, 2011
[Immunologic activity in coronary heart disease and atherosclerosis of the lower extremities]
Katarzyna Mizia-Stec1, Zbigniew Gasior, Barbara Zahorska-Markiewicz
1Katedry i Kliniki Kardiologii, Slaskiej Akademii Medycznej w Katowicach. biboch@slam.katowice.pl
Insights
Generalized atherosclerosis, particularly peripheral artery disease (PAD), elevates immune activation markers like soluble tumor necrosis factor receptor 1 (sTNFR 1) in coronary heart disease patients. An ECG stress test increases E-selectin levels in these patients.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biochemistry
Context:
- Cytokine activation is linked to clinical symptoms in coronary heart disease (CHD) and peripheral artery disease (PAD).
- Assessing immune activation in CHD patients with generalized atherosclerosis is crucial for understanding disease progression.
Purpose:
- To investigate the influence of generalized atherosclerosis on immune activation in CHD patients undergoing an ECG stress test.
- To compare immune marker levels between CHD patients with and without PAD.
Summary:
- 127 CHD patients (21 with PAD, 106 without) and 20 controls were studied.
- Serum levels of TNF alpha, sTNFR 1, E-selectin, and sVCAM-1 were measured pre- and post-ECG stress test.
- Higher TNF alpha and sTNFR 1 levels were observed in CHD patients compared to controls. sTNFR 1 was significantly higher in CHD patients with PAD.
Impact:
- Generalized atherosclerosis, indicated by PAD presence, correlates with heightened immune activation (higher sTNFR 1) in CHD patients.
- ECG stress testing significantly increases E-selectin levels in coronary patients, irrespective of PAD.
- Findings highlight the role of immune system dysregulation in complex cardiovascular disease.
Abstract:
Cytokine activation may be connected to increase of clinical symptoms both of coronary heart disease and lower limbs atherosclerosis. Our aim is to determine the influence of the atherosclerosis generalization upon immune activation in coronary heart disease, with regard to ECG stress test. 127 patients have been included in the study: 21 with stable angina and peripheral artery disease (PAD)--group A, and 106 with stable angina--group B. 20 healthy persons comprised the control group (group K). The serum concentration of TNF alpha, sTNFR 1, E-selectin and sVCAM-1 has been measured before and after the ECG stress test, using the ELISA method. Serum concentration levels of TNF alpha (A: 17.8 +/- 6.2 pg/ml, B: 17.4 +/- 3.8 pg/ml) and sTNFR 1 (A: 1678.5 +/- 600 pg/ml, B: 1376.4 +/- 558 pg/ml) have been significantly higher in both research groups than in the control group K (8.3 +/- 1.4 pg/ml, p < 0.001; 1093.9 +/- 457 pg/ml, p < 0.01). The sTNFR 1 concentration has been significantly higher in group A than in group B (p < 0.05). A significant post-exercise increase in E-selectin serum concentration has been observed, regardless to coincidence of lower limbs atherosclerosis. The atherosclerosis generalization level, e.g. the prevalence of PAD, in patients with coronary heart disease has an influence on immune activation--patients with lower limbs atherosclerosis are characterized by higher sTNFR 1 serum level. The ECG stress test induces the increase of E-selectin serum concentration in coronary patients, regardless of PAD.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Myocarditis I: Introduction
Coronary Artery Disease I: Introduction